Figure 18. In the PrONTO clinical trial, three criteria of retreatment are based in the analysis by OCT:

Figure 18. In the PrONTO clinical trial, three criteria of retreatment are based in the analysis by OCT: Decrease of more than 5 letters of VA (ETDRS) with fluid detected in the macula by OCT(A), increase of more than 100 µm in the central retinal thickness respect to the lowest previous value measured by OCT (B1, B2) or fluid reappearance in the OCT in a previous dry lesion. (C1, C2)